SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001564590-16-027374
Filing Date
2016-11-03
Accepted
2016-11-03 16:19:29
Documents
3
Period of Report
2016-09-30
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 Q3 RESULTS xene-8k_20160930.htm 8-K 24062
2 EX-99 xene-ex99_6.htm EX-99 217725
3 GRAPHIC g2016110319591633810943.jpg GRAPHIC 5126
  Complete submission text file 0001564590-16-027374.txt   250112
Mailing Address 200 - 3650 GILMORE WAY BURNABY A1 V5G 48W
Business Address 200 - 3650 GILMORE WAY BURNABY A1 V5G 48W (604) 484-3300
Xenon Pharmaceuticals Inc. (Filer) CIK: 0001582313 (see all company filings)

IRS No.: 980661854 | State of Incorp.: A1 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36687 | Film No.: 161971861
SIC: 2834 Pharmaceutical Preparations